Bohlega Saeed, Monies Dorothy M, Abulaban Ahmad A, Murad Hatem N, Alhindi Hindi N, Meyer Brian F
Department of Neurosciences, MBC 76, King Faisal Specialist Hospital & Research Centre, PO Box 3354, Riyadh 11211, Kingdom of Saudi Arabia. E-mail:
Neurosciences (Riyadh). 2015 Apr;20(2):173-7. doi: 10.17712/nsj.2015.2.20140547.
Characterization of the phenotypic, pathological, radiological, and genetic findings in 2 Saudi Arabian families with anoctaminopathies, and limb girdle muscular dystrophy type 2L (LGMD2L).
Over a 2-year period from December 2010 to January 2013, the clinical presentations were analyzed and all genes responsible for limb girdle muscular dystrophy (LGMD) were screened in families seen at King Faisal Specialist Hospital and Research Centre, a tertiary care hospital in Riyadh, Saudi Arabia. Out of 66 families with LGMD, we identified 2 families (3.1%) with anoctaminopathy, ANO5 muscular dystrophy.
In the first case, a man presented with asymmetrical calves` muscles weakness and atrophy, which was first noted at age 39. The creatinine kinase (CK) level was >20x normal, muscle biopsy showed necrotizing myopathic changes, and an MRI of the legs showed fatty-tissue replacement to muscle tissue with volume loss involving the gastrocnemius and soleus muscles in an asymmetrical fashion. Minimal disease progression was noted over 18 years of follow up. Exercise induced recurrent rhabdomyolysis was noted over the last 2 years. A novel ANO5 gene mutation (Arg58Trp) was found. In the second family, a male presented at the age of 41 with asymptomatic hyperCkemia and intermittent dyspnea. Over 10 years follow up, he became disabled with muscle cramps, rhabdomyolysis, my oglobinurea, and difficulty ambulating. Muscle biopsy showed necrotizing myopathy and perivascular and interstitial amyloid deposit in skeletal muscle. A homozygous deletion of 11.9 Kb encompassing exon 13 to exon 17 was found in the ANO5 gene. Full cardiac investigations were normal in both patients.
The prevalence of LGMD2L is approximately 3.1% in a Saudi Arabian native LGMD cohort. Slowly progressive, late onset, and asymmetrical weakness was the salient features in these 2 families. The genetic findings were novel and will add to the spectrum of ANO5 known mutations.
对2个患有 anoctaminopathy 及2L型肢带型肌营养不良症(LGMD2L)的沙特阿拉伯家庭的表型、病理、放射学和基因学发现进行特征描述。
在2010年12月至2013年1月的2年期间,对沙特阿拉伯利雅得一家三级护理医院——法赫德国王专科医院和研究中心接诊的家庭的临床表现进行分析,并对所有与肢带型肌营养不良症(LGMD)相关的基因进行筛查。在66个LGMD家庭中,我们识别出2个(3.1%)患有anoctaminopathy,即ANO5型肌营养不良症的家庭。
在第一个病例中,一名男性在39岁时首次被发现有不对称的小腿肌肉无力和萎缩。肌酸激酶(CK)水平高于正常20倍以上,肌肉活检显示坏死性肌病改变,腿部MRI显示肌肉组织被脂肪组织替代,腓肠肌和比目鱼肌体积不对称性减少。在18年的随访中,疾病进展极为缓慢。在过去2年中,观察到运动诱发复发性横纹肌溶解症。发现了一种新的ANO5基因突变(Arg58Trp)。在第二个家庭中,一名男性在41岁时出现无症状性高肌酸激酶血症和间歇性呼吸困难。经过10多年的随访,他因肌肉痉挛、横纹肌溶解症、肌红蛋白尿和行走困难而致残。肌肉活检显示坏死性肌病以及骨骼肌中血管周围和间质淀粉样沉积。在ANO5基因中发现了一个11.9 Kb的纯合缺失,涵盖外显子13至外显子17。两名患者的全面心脏检查均正常。
在沙特阿拉伯本土LGMD队列中,LGMD2L的患病率约为3.1%。这2个家庭的显著特征是疾病进展缓慢、发病较晚且肌无力不对称。基因学发现是新的,将丰富已知的ANO5基因突变谱。